The calcineruin inhibitor cyclosporine a synergistically enhances the susceptibility of Candida albicans biofilms to fluconazole by multiple mechanisms
暂无分享,去创建一个
Wei Jia | Jun Wei | Haiyun Zhang | Gang Li | Caiyun Li | Xiaoming Liu
[1] A. Johri,et al. The activity of RTA2, a downstream effector of the calcineurin pathway, is required during tunicamycin-induced ER stress response in Candida albicans. , 2015, FEMS yeast research.
[2] B. Kjellerup,et al. Elimination of Bloodstream Infections Associated with Candida albicans Biofilm in Intravascular Catheters , 2015, Pathogens.
[3] A. Rodrigues,et al. Adhesion, biofilm formation, cell surface hydrophobicity, and antifungal planktonic susceptibility: relationship among Candida spp. , 2015, Front. Microbiol..
[4] N. Wijayanti,et al. Cyclosporine A decreases the fluconazole minimum inhibitory concentration of Candida albicans clinical isolates but not biofilm formation and cell growth. , 2015, Tropical biomedicine.
[5] Dayong Wang,et al. Effects of Magnolol and Honokiol on Adhesion, Yeast-Hyphal Transition, and Formation of Biofilm by Candida albicans , 2015, PloS one.
[6] S. Falk,et al. Nylon-3 polymers active against drug-resistant Candida albicans biofilms. , 2015, Journal of the American Chemical Society.
[7] B. P. Dias Filho,et al. Effects of fluconazole treatment of mice infected with fluconazole-susceptible and -resistant Candida tropicalis on fungal cell surface hydrophobicity, adhesion and biofilm formation , 2015, Indian journal of medical microbiology.
[8] P. Juvvadi,et al. Calcineurin as a Multifunctional Regulator: Unraveling Novel Functions in Fungal Stress Responses, Hyphal Growth, Drug Resistance, and Pathogenesis. , 2014, Fungal biology reviews.
[9] D. Chorvat,et al. The impact of growth conditions on biofilm formation and the cell surface hydrophobicity in fluconazole susceptible and tolerant Candida albicans , 2014, Folia Microbiologica.
[10] M. Falleni,et al. Biofilms formed by Candida albicans bloodstream isolates display phenotypic and transcriptional heterogeneity that are associated with resistance and pathogenicity , 2014, BMC Microbiology.
[11] Shuyuan Liu,et al. Synergistic effect of fluconazole and doxycycline against Candida albicans biofilms resulting from calcium fluctuation and downregulation of fluconazole-inducible efflux pump gene overexpression. , 2014, Journal of medical microbiology.
[12] J. Su,et al. Human serum inhibits adhesion and biofilm formation in Candida albicans , 2014, BMC Microbiology.
[13] E. Mylonakis,et al. In Vitro and In Vivo Activities of Pterostilbene against Candida albicans Biofilms , 2014, Antimicrobial Agents and Chemotherapy.
[14] C. Rickard,et al. Reducing the risk of infection associated with vascular access devices through nanotechnology: a perspective , 2013, International journal of nanomedicine.
[15] M. Blanco-Blanco,et al. Determination of biofilm production by Candida tropicalis isolated from hospitalized patients and its relation to cellular surface hydrophobicity, plastic adherence and filamentation ability , 2013, Yeast.
[16] Ping Liu,et al. Synergistic effect of doxycycline and fluconazole against Candida albicans biofilms and the impact of calcium channel blockers. , 2013, FEMS yeast research.
[17] Beiqin Yu,et al. Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China. , 2013, The Journal of antimicrobial chemotherapy.
[18] J. Heitman,et al. Posaconazole Exhibits In Vitro and In Vivo Synergistic Antifungal Activity with Caspofungin or FK506 against Candida albicans , 2013, PloS one.
[19] Lan Yan,et al. ECM17-dependent methionine/cysteine biosynthesis contributes to biofilm formation in Candida albicans. , 2013, Fungal genetics and biology : FG & B.
[20] N. Chauhan,et al. Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A , 2012, Annals of Clinical Microbiology and Antimicrobials.
[21] J. Heitman,et al. Calcineurin Is Required for Pseudohyphal Growth, Virulence, and Drug Resistance in Candida lusitaniae , 2012, PloS one.
[22] P. van Dijck,et al. Potent Synergistic Effect of Doxycycline with Fluconazole against Candida albicans Is Mediated by Interference with Iron Homeostasis , 2012, Antimicrobial Agents and Chemotherapy.
[23] R. Rajendran,et al. Fungal Biofilm Resistance , 2012, International journal of microbiology.
[24] F. Lanni,et al. Portrait of Candida albicans Adherence Regulators , 2012, PLoS pathogens.
[25] P. Cobine,et al. Calcium Increases Xylella fastidiosa Surface Attachment, Biofilm Formation, and Twitching Motility , 2011, Applied and Environmental Microbiology.
[26] Li-hua Yu,et al. Possible Inhibitory Molecular Mechanism of Farnesol on the Development of Fluconazole Resistance in Candida albicans Biofilm , 2011, Antimicrobial Agents and Chemotherapy.
[27] Mingchun Li,et al. Alkaline stress triggers an immediate calcium fluctuation in Candida albicans mediated by Rim101p and Crz1p transcription factors. , 2011, FEMS yeast research.
[28] S. Filler,et al. Candida albicans Als3, a Multifunctional Adhesin and Invasin , 2010, Eukaryotic Cell.
[29] Ping Liu,et al. The combination of minocycline and fluconazole causes synergistic growth inhibition against Candida albicans: an in vitro interaction of antifungal and antibacterial agents. , 2010, FEMS yeast research.
[30] K. Hirota,et al. Effect of substrate surface hydrophobicity on the adherence of yeast and hyphal Candida , 2010, Mycoses.
[31] Yong-qiang Zhang,et al. Mechanism of the Synergistic Effect of Amiodarone and Fluconazole in Candida albicans , 2010, Antimicrobial Agents and Chemotherapy.
[32] J. Heitman,et al. Elucidating the Candida albicans calcineurin signaling cascade controlling stress response and virulence. , 2010, Fungal genetics and biology : FG & B.
[33] J. Bagg,et al. Reducing the incidence of denture stomatitis: are denture cleansers sufficient? , 2010, Journal of prosthodontics : official journal of the American College of Prosthodontists.
[34] J. Bouchara,et al. Adherence mechanisms in human pathogenic fungi. , 2008, Medical mycology.
[35] G. Di Bonaventura,et al. Factors associated with adherence to and biofilm formation on polystyrene by Stenotrophomonas maltophilia: the role of cell surface hydrophobicity and motility. , 2008, FEMS microbiology letters.
[36] A. Mitchell,et al. Complementary Adhesin Function in C. albicans Biofilm Formation , 2008, Current Biology.
[37] L. Cowen,et al. The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype , 2008, Nature Reviews Microbiology.
[38] G. Robertson,et al. Bacterial and fungal biofilm infections. , 2008, Annual review of medicine.
[39] J. Heitman,et al. Synergistic Effect of Calcineurin Inhibitors and Fluconazole against Candida albicans Biofilms , 2008, Antimicrobial Agents and Chemotherapy.
[40] J. Lopez-Ribot,et al. A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing , 2008, Nature Protocols.
[41] S. Baliga,et al. Candida biofilms in medical devices: evolving trends. , 2007, Kathmandu University medical journal.
[42] J. Heitman,et al. Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections , 2007, Nature Reviews Microbiology.
[43] A. Mitchell,et al. How to build a biofilm: a fungal perspective. , 2006, Current opinion in microbiology.
[44] A. Mitchell,et al. Genetics and genomics of Candida albicans biofilm formation , 2006, Cellular microbiology.
[45] J. Heitman,et al. Calcineurin Promotes Infection of the Cornea by Candida albicans and Can Be Targeted To Enhance Fluconazole Therapy , 2006, Antimicrobial Agents and Chemotherapy.
[46] Stefan Bentink,et al. Role of Calcineurin in Stress Resistance, Morphogenesis, and Virulence of a Candida albicans Wild-Type Strain , 2006, Infection and Immunity.
[47] William R. Kirkpatrick,et al. Calcineurin Controls Growth, Morphology, and Pathogenicity in Aspergillus fumigatus , 2006, Eukaryotic Cell.
[48] J. Heitman,et al. Immunotherapy with Tacrolimus (FK506) Does Not Select for Resistance to Calcineurin Inhibitors in Candida albicans Isolates from Liver Transplant Patients , 2006, Antimicrobial Agents and Chemotherapy.
[49] D. Sanglard,et al. CRZ1, a target of the calcineurin pathway in Candida albicans , 2006, Molecular microbiology.
[50] James B. Anderson. Evolution of antifungal-drug resistance: mechanisms and pathogen fitness , 2005, Nature Reviews Microbiology.
[51] J. Heitman,et al. The Calcineurin Target, Crz1, Functions in Azole Tolerance but Is Not Required for Virulence of Candida albicans , 2004, Infection and Immunity.
[52] C. d’Enfert,et al. Candida albicans Biofilms: a Developmental State Associated With Specific and Stable Gene Expression Patterns , 2004, Eukaryotic Cell.
[53] R. Darouiche,et al. Candida Infections of Medical Devices , 2004, Clinical Microbiology Reviews.
[54] M. Ghannoum,et al. Mechanism of Fluconazole Resistance in Candida albicans Biofilms: Phase-Specific Role of Efflux Pumps and Membrane Sterols , 2003, Infection and Immunity.
[55] D. Sanglard,et al. Fungicidal Synergism of Fluconazole and Cyclosporine in Candida albicans Is Not Dependent on Multidrug Efflux Transporters Encoded by the CDR1, CDR2, CaMDR1, and FLU1 Genes , 2003, Antimicrobial Agents and Chemotherapy.
[56] J. Heitman,et al. Ergosterol Biosynthesis Inhibitors Become Fungicidal when Combined with Calcineurin Inhibitors against Candida albicans, Candida glabrata, and Candida krusei , 2003, Antimicrobial Agents and Chemotherapy.
[57] L. Samaranayake,et al. Candida glabrata, an emerging fungal pathogen, exhibits superior relative cell surface hydrophobicity and adhesion to denture acrylic surfaces compared with Candida albicans , 2002, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[58] Joseph Heitman,et al. Calcineurin is essential for survival during membrane stress in Candida albicans , 2002, The EMBO journal.
[59] M. Pfaffl,et al. A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.
[60] D. Sanglard,et al. A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole. , 2000, Microbiology.
[61] D. Sanglard,et al. Potent Synergism of the Combination of Fluconazole and Cyclosporine in Candida albicans , 2000, Antimicrobial Agents and Chemotherapy.
[62] S. Kohno,et al. Synergistic effect of ofloxacin and fluconazole against azole-resistant Candida albicans , 2000, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[63] R. Cannon,et al. Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance , 1996, Antimicrobial agents and chemotherapy.
[64] T. Davis,et al. Ca2+-calmodulin promotes survival of pheromone-induced growth arrest by activation of calcineurin and Ca2+-calmodulin-dependent protein kinase , 1996, Molecular and cellular biology.
[65] L. Samaranayake,et al. Relationship between the cell surface hydrophobicity and adherence of Candida krusei and Candida albicans to epithelial and denture acrylic surfaces , 1995, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[66] H. Vanden Bossche. Biochemical targets for antifungal azole derivatives: hypothesis on the mode of action. , 1985, Current topics in medical mycology.